Perfusion of isolated renal tubules.

por Burg, M. B.
Publicado 1972

Primary antibody deficiencies in the context of normal B-cell differentiation

por van der Burg, M
Publicado 2010

A Survey of Emergency Providers Regarding the Current Management of Anterior Shoulder Dislocations

por Baden, D. N., Roetman, M. H., Boeije, T., Mullaart-Jansen, N., Burg, M. D.
Publicado 2020

Phase I/II study of a short course of weekly cisplatin in patients with advanced solid tumours.

por Planting, A. S., van der Burg, M. E., de Boer-Dennert, M., Stoter, G., Verweij, J.
Publicado 1993

Epidermal growth factor receptor in ovarian tumours: correlation of immunohistochemistry with ligand binding assay.

por Henzen-Logmans, S. C., Berns, E. M., Klijn, J. G., van der Burg, M. E., Foekens, J. A.
Publicado 1992

A phase II study of epidoxorubicin in colorectal cancer and the use of cyclosporin-A in an attempt to reverse multidrug resistance.

por Verweij, J., Herweijer, H., Oosterom, R., van der Burg, M. E., Planting, A. S., Seynaeve, C., Stoter, G., Nooter, K.
Publicado 1991

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer.

por Planting, A. S., van der Burg, M. E., van den Bent, M. J., de Boer-Dennert, M., Stoter, G., Verweij, J.
Publicado 1996

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer

por Lim, S L, Smith, P, Syed, N, Coens, C, Wong, H, van der Burg, M, Szlosarek, P, Crook, T, Green, J A
Publicado 2008

Immunodeficiency in a Child with Rapadilino Syndrome: A Case Report and Review of the Literature

por Vollebregt, M. M. G., Malfroot, A., De Raedemaecker, M., van der Burg, M., van der Werff ten Bosch, J. E.
Publicado 2015

Determining physiological VT ablation targets in the era of early VT ablation

por Burg, M, Anderson, R D, Gonna, H, Al-Shaheen, A, Shapira, E, Ben-Dor, A, Hayam, G, Baron, T, Masse, S, Nanthakumar, K
Publicado 2023

A method to identify which patients will have VT substrate ablation targets prior to ablation procedure

por Burg, M, Anderson, R D, Gonna, H, Al-Shaheen, A, Niri, A, Shapira, E, Ben-Dor, A, Hayam, G, Baron, T, Masse, S, Nanthakumar, K
Publicado 2023

Early diagnosis of ataxia telangiectasia in the neonatal phase: a parents’ perspective

por Schoenaker, M. H. D., Blom, M., de Vries, M. C., Weemaes, C. M. R., van der Burg, M., Willemsen, M. A. A. P.
Publicado 2019

Current sample handling methods for measurement of platinum-DNA adducts in leucocytes in man lead to discrepant results in DNA adduct levels and DNA repair.

por Ma, J., Verweij, J., Planting, A. S., de Boer-Dennert, M., van Ingen, H. E., van der Burg, M. E., Stoter, G., Schellens, J. H.
Publicado 1995

Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.

por Schuyer, M., van Staveren, I. L., Klijn, J. G., vd Burg, M. E., Stoter, G., Henzen-Logmans, S. C., Foekens, J. A., Berns, E. M.
Publicado 1996

A phase I/II study of combined weekly systemic cisplatin and locoregional hyperthermia in patients with previously irradiated recurrent carcinoma of the uterine cervix

por Wit, R de, Zee, J van der, Burg, M E L van der, Kruit, W H, Logmans, A, Rhoon, G C van, Verweij, J
Publicado 1999

Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer

por van der Burg, M E L, de Wit, R, van Putten, W L J, Logmans, A, Kruit, W H J, Stoter, G, Verweij, J
Publicado 2002

Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours.

por Schellens, J. H., Ma, J., Planting, A. S., van der Burg, M. E., van Meerten, E., de Boer-Dennert, M., Schmitz, P. I., Stoter, G., Verweij, J.
Publicado 1996

Dose and schedule-finding study of oral topotecan and weekly cisplatin in patients with recurrent ovarian cancer

por Gelderblom, H, Sparreboom, A, Jonge, M J A de, Loos, W J, Wilms, E, Mantel, M A, Hennis, B, Camlett, I, Verweij, J, Burg, M E L van der
Publicado 2001

Logistics of safe and stress-free epicardial access in the electrophysiology lab: creative percutaneous subxiphoid pericardiostomy

por Burg, M, Gonna, H, Anderson, R D, Chandra Srinath Patloori, S, Acosta Velez, J G, Bhaskaran, A, Nair, K, Spears, D, Chauhan, V S, Ha, A C T, Cusimano, R J, Nanthakumar, K
Publicado 2023

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

por Schuyer, M, Burg, M E L van der, Henzen-Logmans, S C, Fieret, J H, Klijn, J G M, Look, M P, Foekens, J A, Stoter, G, Berns, E M J J
Publicado 2001